Aster DM Quality CareNSE:ASTERDM -0.21%80 EBITDA Margin % is 22.04% as of Mar. 2026, which is 49% above its 10-year median of 14.76. GuruFocus rates NSE:ASTERDM with a GF Score™ of 80/100 and a GF Value™ of ₹660.21 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Aster DM Quality Care ranks better than 75.6% on this metric.
Aster DM Quality Care (NSE:ASTERDM) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aster DM Quality Care EBITDA Margin % Related Terms
Aster DM Quality Care EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aster DM Quality Care's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTERDM vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aster DM Quality Care (NSE:ASTERDM) has a EBITDA Margin % of 22.04% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aster DM Quality Care and its competitors. This is 49% above median its historical median of 14.76. Over the past decade, Aster DM Quality Care's EBITDA Margin % has ranged from 11.23 to 37.24. According to the industry distribution chart, Aster DM Quality Care ranks #162 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 24.4%.
Is Aster DM Quality Care's EBITDA Margin % too high?
Aster DM Quality Care's current EBITDA Margin % of 22.04% is 49% above median its 10-year median of 14.76. Over the past 10 years, this metric has ranged from a low of 11.23 to a high of 37.24. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Aster DM Quality Care's value of 22.04% is 115.9% above this industry median. Based on the distribution chart, Aster DM Quality Care ranks #162 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Aster DM Quality Care has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #162 out of 664 companies for EBITDA Margin %. This places Aster DM Quality Care in the top 24% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Aster DM Quality Care's value of 22.04% is 115.9% above this benchmark. Historically, Aster DM Quality Care's own EBITDA Margin % has ranged from 11.23 to 37.24 over the past decade. While the company's 10-year median is 14.76 vs. the industry median of 10.21, Aster DM Quality Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current EBITDA Margin % of 22.04% is 115.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current EBITDA Margin % is 22.04%, which is 49% above median its own 10-year median of 14.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹660.21, compared to a current price of ₹791.55 — trading 19.9% above its estimated fair value. The current EBITDA Margin % is 22.04%, which is 49% above median its 10-year median of 14.76 and 115.9% above the Healthcare Providers & Services industry median of 10.21. Aster DM Quality Care's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current EBITDA Margin % is 22.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹791.55 is trading 19.9% above its estimated GF Value™ of ₹660.21.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
EBITDA Margin %: 22.04% (49% above median its 10-year median of 14.76)
GF Value™: ₹660.21 vs. price of ₹791.55 (19.9% above fair value)
Industry Position: 115.9% above the Healthcare Providers & Services median (#162 of 664)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
80GF Score
Get the complete analysis for NSE:ASTERDM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
